UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
about
Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneAltered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.Skp2: a novel potential therapeutic target for prostate cancerUbcH10 overexpression may represent a marker of anaplastic thyroid carcinomasExpression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinomaUbiquitin proteasome system research in gastrointestinal cancerChanges in gene expression associated with aging commonly originate during juvenile growthHyperISGylation of Old World monkey ISG15 in human cells.Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout miceIdentification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursRING-H2 protein WSSV249 from white spot syndrome virus sequesters a shrimp ubiquitin-conjugating enzyme, PvUbc, for viral pathogenesisUbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.Identification of small molecule inhibitors against UBE2C by using docking studiesIncreased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.Skp2 is a promising therapeutic target in breast cancer.Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy.The APC/C Ubiquitin Ligase: From Cell Biology to TumorigenesisThe Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system.A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2State of the APC/C: organization, function, and structure.UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivoUBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma.E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53Lentivirus-mediated RNA interference targeting UbcH10 reduces cell growth and invasion of human osteosarcoma cells via inhibition of Ki-67 and matrix metalloproteinases.CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.
P2860
Q24293178-5F3FA98F-DC70-4639-8E09-0E0C602F180AQ24321830-76332CF6-4FF6-49DD-B923-EA4464AE3A76Q24550868-930C0128-D3D6-45E2-9382-12A41B778347Q24625558-E2FAE17A-8698-41BC-917A-39212DE22AD8Q24651210-3CD457DC-3A08-47BB-97C6-1100099C7946Q24681972-144ADC21-31FB-4FCF-A9BC-FC719B49AE5BQ26766683-EA87D306-0CBB-4532-A765-C2B256567E2CQ28748811-8F860AC8-F85A-4555-900A-3454C6EB668BQ33344443-FE8CDE36-B66F-4333-9F6B-5CCC0CFB9310Q33420103-7E122254-C2F1-4E33-A48F-787DE0C27E89Q33616502-0CB702B5-E7B7-4E76-B3F3-3EBC43F94904Q33649612-1FF900B1-5A34-4FAA-BB26-F9CCCFB1DCA2Q33655346-0BBE1BFC-2344-47B6-AD8C-ABA4B68A3415Q33758070-6AF952C3-BA90-4D9C-9D28-D08D73A27A38Q33883819-DF9ABA6D-7020-4FF6-9915-9055DF01F338Q34469379-912E7CC5-F995-458A-8538-8896DB13813CQ34527689-26C2F731-D613-4341-A0A2-3D281073CA44Q34534491-1F4F8023-4CA5-409E-9CEC-89C76523E6E2Q34669229-1669D5D3-3B2E-43BB-AA35-5C7F47E65CEBQ34760621-71BCB347-4541-48E0-80C4-24F99AA6B50DQ34839612-98753E01-78D8-4E28-BB6E-EBADB66277B4Q35380465-0D1D6E9E-88AE-4394-B74D-11ABCB226E7DQ35687208-1B52D743-D615-45C7-AFD4-690E86B418FDQ35956214-7086E228-B1D7-4495-900A-48BA199CCD46Q35971862-CCC10A41-E2BA-48A2-BB00-2FA1E92DF5CBQ36029051-C2FFCE66-CAA8-4106-AFCD-6F60827F3864Q36055579-BE2D0D21-4865-45D8-BC4B-A5A6E7CE0EE8Q36066046-5413167E-8526-43C4-A231-F5048443A769Q36867692-ADD8E6B0-1B46-4AC9-9CB5-B2C31A6F9E6EQ36956211-5D78AC9A-8AD7-4305-9B64-05F7ACED0029Q37269659-DC37093E-9F8A-4149-827D-FCC419D12F9DQ37362709-BD340B8B-9F75-41C8-934B-048FACAF953FQ37629009-DA8B47A6-D606-4BD5-9D82-ADCF77DB7A8BQ37662326-A3ACA31C-A1DB-4242-B377-0D034D1999C0Q37665380-CFB9E29D-1BD9-4ED9-8541-9F6B871265D5Q38721719-29E00C11-664D-4F59-A91C-85A21308F50BQ38774471-9368DD80-4F0F-4F1B-8BFD-D032D9E6237EQ38857320-B5AD673D-81EB-4BEB-96F5-64F8B37DE4FFQ39540207-A0A62F37-A113-4FE1-B59A-1451DD0FD47AQ39667550-8AC3A872-C240-4BF5-84BD-B91916557DEE
P2860
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@ast
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@en
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@nl
type
label
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@ast
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@en
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@nl
prefLabel
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@ast
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@en
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
@nl
P2093
P1433
P1476
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme
@en
P2093
Akira Nakagawara
Kou Miyazaki
Masaru Miyazaki
Mineyoshi Aoyama
Toshinori Ozaki
Yoshiaki Okamoto
P304
P407
P577
2003-07-01T00:00:00Z